Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Year: 2003
Type: article
Source: European Radiology
Authors: Peter Reimer, Thomas Balzer
Institution: Städtisches Klinikum Karlsruhe
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1560609297
